DaVita Inc

STU : TRL

€168.00−0.86%

Financials

USD · reported units. Click a value to inspect its source.

CONSOLIDATED STATEMENTS OF INCOME, filing 0000927066-26-000012. USD · reported units.
Reported line item	Jan 1, 2025 to Dec 31, 2025 (current)	Jan 1, 2024 to Dec 31, 2024	Jan 1, 2023 to Dec 31, 2023
Dialysis patient service revenues
Other revenues
Total revenues
Patient care costs
General and administrative
Depreciation and amortization
Equity investment income, net
Goodwill impairment charges
Gain on changes in ownership interests
Total operating expenses
Operating income
Debt expense
Debt extinguishment and modification costs
Other loss, net
Income from continuing operations before income taxes
Income tax expense
Net income from continuing operations
Net income from discontinued operations, net of tax
Net income
Less: Net income attributable to noncontrolling interests
Net income attributable to DaVita Inc.
Basic net income from continuing operationsUSD / share
Basic net incomeUSD / share
Diluted net income from continuing operationsUSD / share
Diluted net incomeUSD / share
Basic shares (in shares)Shares
Diluted shares (in shares)Shares
Net income from continuing operations
Net income from discontinued operations
Net income attributable to DaVita Inc.

30 line items · 3 reported periodsOriginal filing order · parentheses indicate negative amounts

Each column reflects this filing’s presentation. Original line items and period dates are preserved.